Editorial: Neuropathic Pain

Giustino Varrassi; Giacomo Farì; Ameen A. Al Alwany; Matteo L.G. Leoni

doi:10.37349/en.2025.1006101

Exploration of Neuroscience ›› 2025, Vol. 4 ›› Issue (1) :1006101 DOI: 10.37349/en.2025.1006101

research-article

Editorial: Neuropathic Pain

Author information +

History +

PDF (506KB)

Cite this article

Download citation ▾

Giustino Varrassi, Giacomo Farì, Ameen A. Al Alwany, Matteo L.G. Leoni. Editorial: Neuropathic Pain. Exploration of Neuroscience, 2025, 4 (1) : 1006101 DOI:10.37349/en.2025.1006101

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Bouhassira D.Neuropathic pain: Definition, assessment and epidemiology.Rev Neurol (Paris).2019;175:16-25.

[2]	Berfelo T,Krabbenbos IP,van den Berg B,Gefferie SR,Buitenweg JR.Observing nociceptive detection thresholds and evoked potentials in diabetic patients with and without painful neuropathy.Explor Neurosci.2024;3:493-507.

[3]	Peng Y,Zhang Q,Chen S.Sigma-1 receptor as an emerging target for painful diabetic neuropathy—a review.Explor Neurosci.2025;4:100680.

[4]	Pergolizzi J,Varrassi G,Coleman M,Breve F,Christo DK,Christo PJ,et al.The Sigma Enigma: A Narrative Review of Sigma Receptors.Cureus.2023;15:e35756.

[5]	Pergolizzi J Jr,Varrassi G.The Emerging Role of Sigma Receptors in Pain Medicine.Cureus.2023;15:e42626.

[6]	Urits I,Borchart M,Hasegawa M,Kochanski J,Orhurhu V,Viswanath O.An Update of Current Cannabis-Based Pharmaceuticals in Pain Medicine.Pain Ther.2019;8:41-51.

[7]	Demartini L,Bonezzi C.Neuropathic pain: proposal of a mechanism-based treatment.Explor Neurosci.2025;4:100686.

[8]	Kozlovskiy S,Pislyagin E,Menchinskaya E,Chingizova E,Sabutski Y,Polonik S,et al.Antinociceptive effect and anti-inflammatory activity of 1, 4-naphthoquinones in mice.Explor Neurosci.2024;3:39-50.

[9]	Yasin B,Mehta S,Tewfik G,Bekker A.Psychedelics as novel therapeutic agents for chronic pain: mechanisms and future perspectives.Explor Neurosci.2024;3:418-33.

[10]	Matejowsky HG,Kataria S,Spillers NJ,O’Quin CC,Barrie S,Ahmadzadeh S,et al.Interventional procedures for refractory neuropathic pain.Explor Neurosci.2023;2:276-86.

[11]	Pastrak M,Visnjevac O,Visnjevac T,Ma F,Abd-Elsayed A.Safety of Conventional and Pulsed Radiofrequency Lesions of the Dorsal Root Entry Zone Complex (DREZC) for Interventional Pain Management: A Systematic Review.Pain Ther.2022;11:411-45.

[12]	Leung H,Ip JWY,Lam JMK,Lee GKW,Li CCF,Li R,et al.Validation and cultural adaption of the neuropathic pain screening questionnaire painDETECT in Chinese.Explor Neurosci.2024;3:219-30.

[13]	Nikaido T,Tabata S,Shiosakai K,Nakatani T,Sakoda H.Safety and Efficacy of Mirogabalin in Lumbar Spinal Stenosis Patients with Peripheral Neuropathic Pain on NSAIDs: Post Hoc Analysis of the MiroTAS Study.Pain Ther.2025;14:1293-310.

[14]

Überall MA,Simanski C,Zellnig M,Eerdekens M,Engelen S,Heine M,et al.Progressive Response of Repeated Treatment with High-Concentration (179 mg) Capsaicin Patch in Peripheral Neuropathic Pain After Surgical or Traumatic Nerve Injury: Findings from the 12-Month German CASPAR Registry Study.Pain Ther.2025;14:1399-416.